IRONWOOD PHARMACEUTICALS INC shareholders Q1 2023

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 21 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

IRONWOOD PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Wellesley Asset Management 26,609,894$26,706,8461.97%
SHENKMAN CAPITAL MANAGEMENT INC 12,433,000$12,527,9730.95%
ABSOLUTE INVESTMENT ADVISERS, LLC 5,416,000$5,424,1460.80%
III Capital Management 12,000,000$12,048,2100.68%
TENOR CAPITAL MANAGEMENT Co., L.P. 22,000,000$22,162,1130.44%
WOLVERINE ASSET MANAGEMENT LLC 14,791,000$14,853,7280.18%
CAPSTONE INVESTMENT ADVISORS, LLC 32,200,000$32,589,8330.16%
Calamos Advisors LLC 12,500,000$12,551,6250.06%
Citadel Advisors 49,517,000$49,715,0280.01%
Leucadia National 1,060,000$1,066,0110.01%
Nuveen Asset Management, LLC 10,000,000$10,0210.00%
LAKE STREET ADVISORS GROUP, LLC 47,000$470.00%
D.A. DAVIDSON & CO. 135,000$134,9190.00%
BANK OF AMERICA CORP /DE/ 155,000$155,3270.00%
JPMORGAN CHASE & CO 777,000$778,0000.00%
Cetera Advisor Networks LLC 17,000$17,0360.00%
Cetera Advisors LLC 21,000$21,0440.00%
CITIGROUP INC 294,000$294,6200.00%
CREDIT SUISSE AG/ 10,000$10,4510.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%

This page lists IRONWOOD PHARMACEUTICALS INC's shareholders in Q1 2023. To view IRONWOOD PHARMACEUTICALS INC's shareholder history, click here.